Clinicopathological features of hepatoid adenocarcinoma of the stomach: A multicenter retrospective study.

Senichiro Yanagawa Kazuaki TanabeMikihiro KanoRyuichi HottaYoshihiro SaekiNobuaki FujikuniHideki Ohdannull null

Published in: Cancer reports (Hoboken, N.J.) (2024)

Contrary to previous reports suggesting a 3-year survival rate of approximmately 30% for HAS, our findings indicate that the prognosis for HAS may not be as poor as reported previously. This study contributes valuable insights into the management and potential treatment strategies for HAS.

Keyphrases

squamous cell carcinoma
risk assessment
radiation therapy
human health
climate change
drug induced